Terms ending in 2040
Every in-force patent on Amgen Inc.'s record whose computed term ends in 2040, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 11,986,624 | Insertion Mechanism for Drug Delivery Device In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,433,402 | Magnetic Assisted Separation Apparatuses and Related Methods In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,807,624 | Substituted Pyrimidinones as Agonists of the Apj Receptor In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,299,491 | Synthesis of Key Intermediate of Kras G12C Inhibitor Compound In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,391,689 | Synthesis of Key Intermediate of Kras G12C Inhibitor Compound In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,612,366 | Salts and Crystal Forms of Omecamtiv Mecarbil In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 11,672,733 | Gas Permeable Sealing Member for Drug Container and Methods of Assembly In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,178,991 | Wearable Injector with Sterile Adhesive Patch In force · High confidence | Amgen Inc. | In force | High confidence | |
| US D1,065,512 | Autoinjector with Removable Cap In force · High confidence | Amgen Inc. | In force | High confidence | |
| US 12,552,877 | ANTI-TL1A Antibodies and Uses Thereof In force · High confidence | Amgen Inc. | In force | High confidence | |
| 55 more term ends in 2040 · Pro | |||||
10 of 65 patents shown. Soonest term end first, then patent number.
Pro members see all 65.
Updated Nov 19, 2026 · includes USPTO assignment data published Nov 18, 2026, status data published Nov 19, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.